SAM
TEVA icon

SEB Asset Management’s Teva Pharmaceuticals TEVA Stock Holding History

SEB Asset Management’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$57.4M Sell
1,695,648
-281,489
-14% -$9.38M 0.22% 96
2026
Q1 		$59.6M Buy
+1,977,137
New +$63.6M 0.25% 80

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

SEB Asset Management's TEVA Position: Q2 2026 in Review

SEB Asset Management reduced its Teva Pharmaceuticals (TEVA) stake by 14% in Q2 2026, selling an estimated $9.38M and leaving 1,695,648 shares worth $57.4M. The position accounts for 0.22% of the portfolio, ranked #96.

SEB Asset Management first reported a position in TEVA in Q1 2026 and has held it in 2 quarters since. The position peaked at $59.6M in Q1 2026. 639 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • SEB Asset Management held 1,695,648 shares of Teva Pharmaceuticals worth $57.4M as of Q2 2026.
  • SEB Asset Management sold 281,489 Teva Pharmaceuticals shares in Q2 2026, an estimated $9.38M.
  • Teva Pharmaceuticals made up 0.22% of SEB Asset Management's portfolio in Q2 2026, its #96 holding.
  • SEB Asset Management first reported a position in Teva Pharmaceuticals in Q1 2026 and has held it in 2 quarters since.
  • SEB Asset Management's Teva Pharmaceuticals position peaked at $59.6M in Q1 2026.
  • 639 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on SEB Asset Management's 13F filing for Q2 2026, filed 4 Aug 2026.